A practical guideline for management of hypertension in patients with diabetes

Journal Medical Libanais

Volumn 48, Issue 6, 2000, Pages 392-395

  Azar, S ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; INDAPAMIDE; NIFEDIPINE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ANAMNESIS; DIABETES MELLITUS; HUMAN; HYPERTENSION; LABORATORY TEST; LIFESTYLE; METABOLIC DISORDER; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; REVIEW;

ANTIHYPERTENSIVE AGENTS; COMBINED MODALITY THERAPY; DIABETES COMPLICATIONS; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; LIFE STYLE; PRACTICE GUIDELINES;

EID: 0034434949     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
2. Effect of intensive blood glucose control policy with metformin on complications in type 2 diabetes : (UKPDS 34)
3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes : UKPDS 38
4. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes : UKPDS 39
5. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes : UKPDS 40
6. UK prospective diabetes study 17 : A nine-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus
7. Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus : UKPDS 23
8. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV)
9. Hypertension in diabetic nephropathy: Prevention and treatment
10. Insulin dependent diabetes mellitus and hypertension
11. Central role of sodium in hypertension in diabetic subjects
12. A controlled clinical trial of angiotensin-converting enzyme inhibition in type 1 diabetic nephropathy : Study design and patient characteristics
13. The effect of angiotensin-converting enzyme inhibition in diabetic nephropathy
14. Standards of medical care for patients with diabetes mellitus
15. Report of the Canadian Hypertension Society Consensus Conference. 5. Hypertension and diabetes
16. Effect of thiazides on carbohydrate metabolism in patients with hypertension
17. Management of hypertension in diabetes
18. Safety and tolerability of Iosartan potassium, an antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
19. Converting-enzyme inhibitors in the treatment of hypertension
20. Risks of angiotensin-converting enzyme inhibition during pregnancy : Experimental and clinical evidence, potential mechanisms, and recommendations for use
21. 2+: Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients
22. Treating hypertension in the diabetic patient : Therapeutic goals and the role of calcium channel blockers
23. Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease
24. The risk of myocardial infarction associated with antihypertensive drug therapies
25. Calcium channel blockers and myocardial infarction : A hypothesis formulated but not yet tested
26. Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy
27. Comparison between perindropril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria
28. Single drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo
29. Diuretic therapy for hypertension and the risk of primary cardiac arrest
30. Excess mortality associated with diuretic therapy in diabetes mellitus
31. Prevention of stroke by antihypertensive drug treatment in older patients with isolated systolic hypertension: Final results of Systolic Hypertension in the Elderly Program (SHEP)
32. Effect of dixazosin on insulin sensitivity in hypertensive non-insulin-dependent diabetic patients
33. Doxazosin therapy in the treatment of diabetic hypertension